Search hospitals > New York > Rochester

University of Rochester Medical Center

Claim this profile
Rochester, New York 14618
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in HIV Infection
Conducts research for Infections and Infestations
Conducts research for Diffuse Large B-Cell Lymphoma
Conducts research for Lymphoma
762 reported clinical trials
45 medical researchers
Photo of University of Rochester Medical Center in RochesterPhoto of University of Rochester Medical Center in RochesterPhoto of University of Rochester Medical Center in Rochester

Summary

University of Rochester Medical Center is a medical facility located in Rochester, New York. This center is recognized for care of Human Immunodeficiency Virus Infection, HIV Infection, Infections and Infestations, Diffuse Large B-Cell Lymphoma, Lymphoma and other specialties. University of Rochester Medical Center is involved with conducting 762 clinical trials across 826 conditions. There are 45 research doctors associated with this hospital, such as Richard G. Moore, Brea Lipe, MD, Anton Porsteinsson, MD, and Daniel Lachant.

Top PIs

Clinical Trials running at University of Rochester Medical Center

Breast Cancer
Bladder Cancer
Multiple Myeloma
Lymphoma
Coronavirus
Pulmonary Embolism
Gestational Diabetes
Lung Cancer
Non-Small Cell Lung Cancer
Plasma Cell Neoplasm
Image of trial facility.

Gedatolisib + Fulvestrant +/- Palbociclib

for Advanced Breast Cancer

This trial is testing a combination of drugs to treat advanced breast cancer that has not responded to other treatments. The drugs work by blocking growth signals, breaking down estrogen receptors, and stopping cell division. Tamoxifen is a commonly used drug that blocks estrogen receptors to treat breast cancer, but resistance to it often develops.
Recruiting2 awards Phase 311 criteria
Image of trial facility.

Neratinib + Endocrine Therapy + Trastuzumab

for Breast Cancer

This trial involves treating breast cancer patients with three drugs: neratinib, an aromatase inhibitor, and trastuzumab. These drugs work together to block cancer growth signals, lower estrogen levels, and help the immune system attack cancer cells. The treatment is aimed at patients with HER2-positive breast cancer who may not respond well to standard treatments. Trastuzumab is a well-established treatment for HER2-positive breast cancer, often used in combination with other therapies.
Recruiting1 award Phase 216 criteria
Image of trial facility.

Alisertib + Endocrine Therapy

for Breast Cancer

PUMA-ALI-1201 is a randomized, dose optimization, multicenter, Phase 2 study of alisertib administered in combination with endocrine therapy in participants with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two prior lines of endocrine therapy in the recurrent or metastatic setting. This study is intended to evaluate the optimal alisertib dose administered in combination with the selected endocrine therapy. The study is also planned to evaluate the efficacy, safety, and pharmacokinetics of alisertib in combination with endocrine and to identify the biomarker-defined subgroup(s) that may benefit most from combined alisertib and endocrine therapy.
Recruiting1 award Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Rochester Medical Center?
Where is University of Rochester Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Rochester Medical Center accept?
What awards or recognition has University of Rochester Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security